EZH2 and atherosclerosis: Since the H3K27 methyltransferases have opposing effects on this histone mark and the fact that EZH2 controls macrophage inflammatory responses, we hypothesized that inhibition of the H3K27 methyltransferase EZH2 in myeloid cells improves atherosclerosis outcome.